BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23968571)

  • 1. Loss-of-SIRT1 function during vascular ageing: hyperphosphorylation mediated by cyclin-dependent kinase 5.
    Bai B; Vanhoutte PM; Wang Y
    Trends Cardiovasc Med; 2014 Feb; 24(2):81-4. PubMed ID: 23968571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis.
    Bai B; Liang Y; Xu C; Lee MY; Xu A; Wu D; Vanhoutte PM; Wang Y
    Circulation; 2012 Aug; 126(6):729-40. PubMed ID: 22753194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 in Endothelial Cells as a Novel Target for the Prevention of Early Vascular Aging.
    Guo Y; Xu A; Wang Y
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):465-73. PubMed ID: 26657715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
    Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis.
    Kitada M; Ogura Y; Koya D
    Aging (Albany NY); 2016 Oct; 8(10):2290-2307. PubMed ID: 27744418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acetylation of cyclin-dependent kinase 5 at lysine 33 regulates kinase activity and neurite length in hippocampal neurons.
    Lee J; Ko YU; Chung Y; Yun N; Kim M; Kim K; Oh YJ
    Sci Rep; 2018 Sep; 8(1):13676. PubMed ID: 30209341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis.
    Ota H; Eto M; Ogawa S; Iijima K; Akishita M; Ouchi Y
    J Atheroscler Thromb; 2010 May; 17(5):431-5. PubMed ID: 20215708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial SIRT1 as a Target for the Prevention of Arterial Aging: Promises and Challenges.
    Begum MK; Konja D; Singh S; Chlopicki S; Wang Y
    J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S63-S77. PubMed ID: 34840264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-SIRT1 Axis Plays a Pivotal Role in Protecting Arteries Against Menopause-Induced Senescence and Atherosclerosis.
    Sasaki Y; Ikeda Y; Miyauchi T; Uchikado Y; Akasaki Y; Ohishi M
    J Atheroscler Thromb; 2020 Jan; 27(1):47-59. PubMed ID: 31105126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence.
    Chen H; Wan Y; Zhou S; Lu Y; Zhang Z; Zhang R; Chen F; Hao D; Zhao X; Guo Z; Liu D; Liang C
    Sci China Life Sci; 2012 Jun; 55(6):467-73. PubMed ID: 22744176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model.
    Wang Y; Liang Y; Vanhoutte PM
    FEBS Lett; 2011 Apr; 585(7):986-94. PubMed ID: 21130086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CDK5 Restores Sevoflurane-Induced Cognitive Dysfunction by Promoting SIRT1-Mediated Autophagy.
    Yang X; Zhang W; Wu H; Fu S; Yang J; Liu S; Zhao Y; Zhang X; Liu J
    Cell Mol Neurobiol; 2020 Aug; 40(6):955-965. PubMed ID: 31950315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells.
    Takemura A; Iijima K; Ota H; Son BK; Ito Y; Ogawa S; Eto M; Akishita M; Ouchi Y
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2054-62. PubMed ID: 21719763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to investigate the role of SIRT1 in endothelial senescence.
    Bai B; Wang Y
    Methods Mol Biol; 2013; 965():327-39. PubMed ID: 23296669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between SIRT1 and p66Shc in vascular diseases.
    Chen HZ; Wan YZ; Liu DP
    Trends Cardiovasc Med; 2013 Oct; 23(7):237-41. PubMed ID: 23499302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis.
    Winnik S; Stein S; Matter CM
    Curr Vasc Pharmacol; 2012 Nov; 10(6):693-6. PubMed ID: 23259556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1: a novel target to prevent atherosclerosis.
    Yu W; Fu YC; Chen CJ; Wang X; Wang W
    J Cell Biochem; 2009 Sep; 108(1):10-3. PubMed ID: 19562740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 improves VSMC functions in atherosclerosis.
    Zhang MJ; Zhou Y; Chen L; Wang X; Long CY; Pi Y; Gao CY; Li JC; Zhang LL
    Prog Biophys Mol Biol; 2016 May; 121(1):11-5. PubMed ID: 27080738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 deacetylation by SIRT1 decreases during protein kinase CKII downregulation-mediated cellular senescence.
    Jang SY; Kim SY; Bae YS
    FEBS Lett; 2011 Nov; 585(21):3360-6. PubMed ID: 21968188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of SIRT1 in diabetic vascular dysfunction.
    Orimo M; Minamino T; Miyauchi H; Tateno K; Okada S; Moriya J; Komuro I
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):889-94. PubMed ID: 19286634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.